Pemphigus: current and future therapeutic strategies
D Didona, R Maglie, R Eming, M Hertl - Frontiers in immunology, 2019 - frontiersin.org
Pemphigus encompasses a heterogeneous group of autoimmune blistering diseases, which
affect both mucous membranes and the skin. The disease usually runs a chronic-relapsing …
affect both mucous membranes and the skin. The disease usually runs a chronic-relapsing …
Guidelines on the Use of therapeutic apheresis in clinical practice–Evidence‐Based approach from the Writing Committee of the American Society for Apheresis: The …
L Connelly‐Smith, CR Alquist, NA Aqui… - Journal of clinical …, 2023 - Wiley Online Library
Abstract The American Society for Apheresis (ASFA) Journal of Clinical Apheresis (JCA)
Special Issue Writing Committee is charged with reviewing, updating, and categorizing …
Special Issue Writing Committee is charged with reviewing, updating, and categorizing …
[HTML][HTML] Pemphigus vulgaris
AM Porro, CA Seque, MCC Ferreira - Anais brasileiros de …, 2019 - SciELO Brasil
Pemphigus vulgaris is a chronic autoimmune bullous dermatosis that results from the
production of autoantibodies against desmogleins 1 and 3. It is the most frequent and most …
production of autoantibodies against desmogleins 1 and 3. It is the most frequent and most …
[HTML][HTML] Pemphigus vulgaris and bullous pemphigoid: update on diagnosis and treatment
V Di Lernia, DM Casanova, M Goldust… - Dermatology practical & …, 2020 - ncbi.nlm.nih.gov
Autoimmune bullous disorders are a heterogeneous spectrum of skin disorders
characterized by the production of autoantibodies against adhesion molecules of the skin …
characterized by the production of autoantibodies against adhesion molecules of the skin …
Mechanisms causing acantholysis in pemphigus-lessons from human skin
Pemphigus vulgaris (PV) is an autoimmune bullous skin disease caused primarily by
autoantibodies (PV-IgG) against the desmosomal adhesion proteins desmoglein (Dsg) 1 …
autoantibodies (PV-IgG) against the desmosomal adhesion proteins desmoglein (Dsg) 1 …
Novel insights in CAR-NK cells beyond CAR-T cell technology; promising advantages
CAR-T (chimeric antigen receptor T cell) technology, which has recently showed successful
results in the treatment of hematological tumors, has been the focus of attention as one of …
results in the treatment of hematological tumors, has been the focus of attention as one of …
Autoimmune pemphigus: latest advances and emerging therapies
Pemphigus represents a group of rare and severe autoimmune intra-epidermal blistering
diseases affecting the skin and mucous membranes. These painful and debilitating diseases …
diseases affecting the skin and mucous membranes. These painful and debilitating diseases …
Targeted therapies for autoimmune bullous diseases: current status
KT Amber, R Maglie, F Solimani, R Eming, M Hertl - Drugs, 2018 - Springer
Autoimmune bullous skin disorders are rare but meaningful chronic inflammatory diseases,
many of which had a poor or devastating prognosis prior to the advent of …
many of which had a poor or devastating prognosis prior to the advent of …
Bullous autoimmune dermatoses
SC Hofmann, HA Juratli, R Eming - JDDG: Journal der …, 2018 - Wiley Online Library
Pathophysiologically, bullous autoimmune dermatoses are caused by autoantibodies
directed against adhesion molecules or structural proteins of the skin and mucous …
directed against adhesion molecules or structural proteins of the skin and mucous …